Clinical trials
Phase 4 Non-alcoholic Fatty Liver Disease trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2016 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 4 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 17 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Affiliated Hospital of Nantong University | 1 |
| Central Hospital, Nancy, France | 1 |
| Consorcio Centro de Investigación Biomédica en Red (CIBER) | 1 |
| Getz Pharma | 1 |
| Huntington Medical Research Institutes | 1 |
| Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | 1 |
| Jinnah Postgraduate Medical Centre | 1 |
| Leiden University Medical Center | 1 |
| Meir Medical Center | 1 |
| Nanfang Hospital, Southern Medical University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Non-alcoholic Fatty Liver Disease | 17 |
| Diabetes Mellitus, Type 2 | 4 |
| Diabetes Mellitus | 2 |
| Dyslipidemias | 2 |
| Fatty Liver | 2 |
| Obesity | 2 |
| Glucose Intolerance | 1 |
| Lipid Metabolism Disorders | 1 |
| Metabolic Syndrome | 1 |
| Polycystic Ovary Syndrome | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.